Full investment portfolio of the Relevant Investments as at 31 August 2021
| Relevant Investment | Type | Primary Listing | Country of Issuer | Currency | Total Cost | Mark-to-market Value | Weighting of GAV *(%) | Credit Rating (S&P's/Moody's/Fitch's) |
| NANFUN 4 ½ 09/20/22 EMTN | Bond | Singapore Exchange | BVI | USD | HK$9,797,000 | HK$9,629,000 | 0.0141% | BBB- / Baa3 / - |
| NANFUN 4 ⅞ 05/29/24 EMTN | Bond | Singapore Exchange | BVI | USD | HK$56,602,000 | HK$57,341,000 | 0.0843% | BBB- / Baa3 / - |
| HKTGHD 3 ¾ 03/08/23 | Bond | Singapore Exchange | BVI | USD | HK$49,641,000 | HK$51,117,000 | 0.0751% | BBB / Baa2 / - |
| CAPG 6.35 02/08/24 | Bond | Singapore Exchange | Cayman Islands | USD | HK$38,747,000 | HK$36,365,000 | 0.0534% | B / B2 / BB |
| MOLAND 11 ½ 11/13/22 | Bond | Singapore Exchange | Cayman Islands | USD | HK$3,809,000 | HK$3,664,000 | 0.0054% | - / B3 / B |
| GRNCH 5.65 07/13/25 | Bond | Hong Kong Exchange | Cayman Islands | USD | HK$9,300,000 | HK$9,675,000 | 0.0142% | - / Ba3 / - |
| CIFIHG 5.95 10/20/25 | Bond | Hong Kong Exchange | Cayman Islands | USD | HK$77,488,000 | HK$81,827,000 | 0.1202% | BB- / - / BB |
| CAPG 4.2 01/20/22 | Bond | Singapore Exchange | Cayman Islands | USD | HK$29,945,000 | HK$29,706,000 | 0.0437% | - / - / - |
| ZHPRHK 5.95 11/18/21 | Bond | Hong Kong Exchange | Cayman Islands | USD | HK$38,772,000 | HK$38,979,000 | 0.0573% | - / - / - |
| CAPG 4 ¾ 09/01/21 | Bond | Unlisted | Cayman Islands | USD | HK$232,509,000 | HK$233,610,000 | 0.3433% | - / - / - |
| AGILE 4 ¼ 11/01/21 | Bond | Unlisted | Cayman Islands | USD | HK$542,521,000 | HK$552,939,000 | 0.8126% | - / - / - |
| KWGPRO 4 ⅜ 12/29/21 | Bond | Unlisted | Cayman Islands | USD | HK$775,350,000 | HK$784,852,000 | 1.1534% | - / - / - |
| EC Healthcare (Stock Code: 2138.HK) | Equity | Hong Kong Exchange | Cayman Islands | HKD | HK$51,810,000 | HK$132,393,000 | 0.1946% | N/A |
| Total | HK$1,916,291,000 | HK$2,022,097,000 | 2.9716% | |||||